PolyPeptide Group AG announced the resignation by its CEO Raymond De Vré. Mr. De Vré took over as CEO upon completion of the Company's IPO and has played an important role in the Company's transformation into a public company. Mr. De Vré will remain available for a smooth transition.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.55 CHF | +2.43% | +1.90% | +68.66% |
03-12 | PolyPeptide Group AG Provides Earnings Guidance for 2024 | CI |
03-12 | Transcript : PolyPeptide Group AG, 2023 Earnings Call, Mar 12, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+68.66% | 1.07B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PPGN Stock
- News PolyPeptide Group AG
- PolyPeptide Group AG Announces Resignation of Raymond De Vré as CEO